The impact of high-cost pharmaceuticals on self-funded plans

Using high-cost pharmaceuticals to treat a range of health conditions is an exciting development for patients and their families but these prescriptions usually come with a hefty price tag.

In this issue of the Inside Track—Symetra’s educational series for benefits professionals—we give a general overview of three high-cost pharmaceutical categories—biologics, specialty pharmaceuticals and compound drugs—and discuss how charges for these types of prescriptions can affect self-funded medical plans.